Business Context and Reporting Period
This Form 8-K filing by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) is dated January 28, 2014. The report discloses the material terms of a separation agreement with Jeffery A. McCaulley, the former President of Zimmer Reconstructive, whose departure became effective on January 10, 2014.
Key Financial Metrics
The filing does not provide general company financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on the specific compensation costs associated with the executive separation:
- Lump Sum Severance: $275,000 (equivalent to six months of base salary).
- Health Insurance Continuation: $8,520.78 (cost of COBRA coverage for six months).
- Outplacement Services: Up to $25,000.
- Performance Bonus: Eligible for a lump sum payment equal to the 2013 Executive Performance Incentive Plan bonus value, payable in or around March 2014. The specific dollar amount is not disclosed in this text.
- Equity: Accelerated vesting of time-based conditions on certain stock options and restricted stock units; vested options must be exercised by April 10, 2014.
Material Changes
The primary material change is the formalization of the executive departure and the associated financial obligations. The filing clarifies that the separation agreement was entered into on January 28, 2014, following the initial announcement of Mr. McCaulley's departure on January 15, 2014.
Outlook, Risks, and Contingencies
Contingencies and Clawbacks: All payments and benefits under the separation agreement and stock incentive plans are subject to forfeiture, clawback, and full repayment if Mr. McCaulley violates the separation agreement, the general release, or the confidentiality, non-competition, and non-solicitation agreements.
Revocation Period: The separation agreement and general release remain subject to revocation by Mr. McCaulley through February 4, 2014.
Key Facts for Investor Verification
- Verify the exact value of the 2013 performance bonus payable to Mr. McCaulley, as the specific amount is not listed in this filing.
- Confirm whether the separation agreement was revoked by Mr. McCaulley prior to the February 4, 2014 deadline.
- Monitor future filings for any disclosures regarding clawback provisions if the executive violates non-compete or confidentiality terms.
- Note that the company name in the filing header is "Zimmer Holdings, Inc.", reflecting the name prior to the merger that created Zimmer Biomet Holdings, Inc.